Ana M. Mendes‐Pereira

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

Ana M. Mendes‐Pereira, Sarah A. Martin, Rachel Brough et al. · EMBO Molecular Medicine · 2009 · 633 citations · Full text

Life Sciences, Molecular Biology, Oncology +14

PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

Konstantin J. Dedes, Daniel Wetterskog, Ana M. Mendes‐Pereira et al. · Science Translational Medicine · 2010 · 255 citations

Life Sciences, Molecular Biology, Oncology +15

Genome-wide functional screen identifies a compendium of genes affecting sensitivity to tamoxifen

Ana M. Mendes‐Pereira, David Sims, Tim Dexter et al. · Proceedings of the National Academy of Sciences · 2011 · 147 citations

Life Sciences, Genetics, Molecular Biology +17

Functional Viability Profiles of Breast Cancer

Rachel Brough, Jessica Frankum, David Sims et al. · Cancer Discovery · 2011 · 143 citations · Full text

Pharmacy, Molecular Biology, Oncology +15

High-throughput RNA interference screening using pooled shRNA libraries and next generation sequencing

David Sims, Ana M. Mendes‐Pereira, Jessica Frankum et al. · Genome biology · 2011 · 123 citations · Full text

Life Sciences, Genetics, Molecular Biology +10